LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:
----------
FTSE 100
----------
GOLDMAN RAISES GLAXOSMITHKLINE TO 'BUY' ('NEUTRAL') - PRICE TARGET 1670 (1700) PENCE
----------
GOLDMAN RAISES NATIONAL GRID PRICE TARGET TO 786 (780) PENCE - 'SELL'
----------
GOLDMAN CUTS SSE PRICE TARGET TO 1460 (1472) PENCE - 'SELL'
----------
Shore Capital Puts Tesco Under Review, From Hold
----------
FTSE 250
----------
GOLDMAN CUTS PENNON GROUP TO 'SELL' ('NEUTRAL') - TARGET 740 (743) PENCE
----------
BERENBERG CUTS THOMAS COOK PRICE TARGET TO 165 (170) PENCE - 'BUY'
----------
Jefferies Cuts Dunelm Price Target To 1,025p from 1,150p, Buy
----------
MAIN MARKET AND AIM
----------
TRADERS: JEFFERIES INITIATES SAFESTORE WITH 'BUY'
----------
CREDIT SUISSE CUTS SHANKS GROUP TO 'NEUTRAL' ('OUTPERFORM') - TARGET 105 (115) PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.
![Sharecast News](https://static.lse.co.uk/images/news-logos/sharecast-news-logo.png)
GSK's Nucala gets fresh approval in China
(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.
Read more